Expansion or Elimination of B Cells In Vivo: Dual Roles for CD40- and Fas (CD95)-Ligands Modulated by the B Cell Antigen Receptor
Open Access
- 1 October 1996
- Vol. 87 (2) , 319-329
- https://doi.org/10.1016/s0092-8674(00)81349-5
Abstract
No abstract availableKeywords
This publication has 69 references indexed in Scilit:
- A License to KillCell, 1996
- IMMUNE REGULATION BY CD40 AND ITS LIGAND GP39Annual Review of Immunology, 1996
- The role of bcl‐xL in CD40‐mediated rescue from anti‐μ‐induced apoptosis in WEHI‐231 B lymphoma cellsEuropean Journal of Immunology, 1995
- Fas(CD95)/FasL interactions required for programmed cell death after T-cell activationNature, 1995
- Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomasNature, 1995
- The Role of APO‐1‐Mediated Apoptosis in the Immune SystemImmunological Reviews, 1994
- The random inactivation of the X chromosome carrying the defective gene responsible for X-linked hyper IgM syndrome (X-HIM) in female carriers of HIGM1.Journal of Clinical Investigation, 1994
- The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndromeCell, 1993
- Expression of anti-DNA immunoglobulin transgenes in non-autoimmune miceNature, 1991
- Evans syndrome in childhoodThe Journal of Pediatrics, 1980